OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 65 filers reported holding OVID THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,175 | +17.0% | 306 | 0.0% | 0.00% | – |
| Q2 2023 | $1,004 | +17.6% | 306 | -7.6% | 0.00% | – |
| Q1 2023 | $854 | -14.6% | 331 | 0.0% | 0.00% | – |
| Q4 2022 | $1,000 | 0.0% | 331 | 0.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 331 | 0.0% | 0.00% | – |
| Q2 2022 | $1,000 | 0.0% | 331 | 0.0% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 331 | 0.0% | 0.00% | – |
| Q4 2021 | $1,000 | 0.0% | 331 | -23.2% | 0.00% | – |
| Q3 2021 | $1,000 | 0.0% | 431 | +6.2% | 0.00% | – |
| Q2 2021 | $1,000 | -50.0% | 406 | -19.8% | 0.00% | – |
| Q1 2021 | $2,000 | +100.0% | 506 | 0.0% | 0.00% | – |
| Q4 2020 | $1,000 | -66.7% | 506 | -4.7% | 0.00% | – |
| Q3 2020 | $3,000 | -50.0% | 531 | -36.1% | 0.00% | – |
| Q2 2020 | $6,000 | – | 831 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AWH Capital, L.P. | 230,000 | $407,000 | 0.69% |
| BVF INC/IL | 3,293,000 | $5,829,000 | 0.65% |
| COWEN INC. | 1,101,414 | $1,950,000 | 0.21% |
| ARMISTICE CAPITAL, LLC | 1,780,000 | $3,151,000 | 0.17% |
| Granite Point Capital Management, L.P. | 417,857 | $740,000 | 0.07% |
| Redmile Group, LLC | 737,550 | $1,305,000 | 0.04% |
| Tekla Capital Management LLC | 496,977 | $880,000 | 0.04% |
| Fairpointe Capital LLC | 101,000 | $179,000 | 0.01% |
| Alyeska Investment Group, L.P. | 225,000 | $398,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 84,440 | $149,000 | 0.00% |